AbCellera

Categories

Description

A biotechnology company focused on developing antibody-based medicines through an integrated platform.

Summary

AbCellera utilizes a proprietary platform that combines biology, computation, and engineering to discover and develop antibody-based medicines. The company's approach aims to streamline the journey from target identification to the clinic, addressing a range of therapeutic areas. With over 100 programs since 2015, AbCellera collaborates with partners to tackle complex transmembrane proteins, bispecifics, and antibody-drug conjugates, aiming to bring innovative treatments to patients.

Use Cases

• Developing a non-hormonal treatment for vasomotor symptoms associated with menopause.
• Creating a monoclonal antibody for the treatment of moderate-to-severe atopic dermatitis.